题名 | Hydrogen Sulfide in Diabetic Complications Revisited: The State of the Art, Challenges, and Future Directions |
作者 | |
通讯作者 | Xiaowei,Nie; Jinsong,Bian |
共同第一作者 | Haijian,Sun; Siping,Xiong; Zi-Chao,Wang |
发表日期 | 2023
|
DOI | |
发表期刊 | |
ISSN | 1523-0864
|
EISSN | 1557-7716
|
卷号 | 38期号:1-3 |
摘要 | Significance: Diabetes and its related complications are becoming an increasing public health problem that affects hundreds of millions of people globally. Increased disability and mortality rate of diabetic individuals are closely associated with various life-threatening complications, such as atherosclerosis, nephropathy, retinopathy, and cardiomyopathy.Recent Advances: Conventional treatments for diabetes are still limited because of undesirable side effects, including obesity, hypoglycemia, and hepatic and renal toxicity. Studies have shown that hydrogen sulfide (H2S) plays a critical role in the modulation of glycolipid metabolism, pancreatic beta cell functions, and diabetic complications.Critical Issues: Preservation of endogenous H2S systems and supplementation of H2S donors are effective in attenuating diabetes-induced complications, thus representing a new avenue to treat diabetes and its associated complications.Future Directions: This review systematically recapitulates and discusses the most recent updates regarding the therapeutic effects of H2S on diabetes and its various complications, with an emphasis on the molecular mechanisms that underlie H2S-mediated protection against diabetic complications. Furthermore, current clinical trials of H2S in diabetic populations are highlighted, and the challenges and solutions to the clinical transformation of H2S-derived therapies in diabetes are proposed. Finally, future research directions of the pharmacological actions of H2S in diabetes and its related complications are summarized. Antioxid. Redox Signal. 38, 18-44. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 通讯
|
WOS研究方向 | Biochemistry & Molecular Biology
; Endocrinology & Metabolism
|
WOS类目 | Biochemistry & Molecular Biology
; Endocrinology & Metabolism
|
WOS记录号 | WOS:000917909700002
|
出版者 | |
ESI学科分类 | BIOLOGY & BIOCHEMISTRY
|
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:4
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/416301 |
专题 | 南方科技大学 南方科技大学医学院_药理学系 |
作者单位 | 1.Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, 518055 China. 2.State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing 210009, China 3.Department of Pathology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518033, Guangdong, China 4.Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen People’s Hospital (The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518055, China |
通讯作者单位 | 南方科技大学 |
推荐引用方式 GB/T 7714 |
Haijian,Sun,Siping,Xiong,Zi-Chao,Wang,et al. Hydrogen Sulfide in Diabetic Complications Revisited: The State of the Art, Challenges, and Future Directions[J]. ANTIOXIDANTS & REDOX SIGNALING,2023,38(1-3).
|
APA |
Haijian,Sun,Siping,Xiong,Zi-Chao,Wang,Xiaowei,Nie,&Jinsong,Bian.(2023).Hydrogen Sulfide in Diabetic Complications Revisited: The State of the Art, Challenges, and Future Directions.ANTIOXIDANTS & REDOX SIGNALING,38(1-3).
|
MLA |
Haijian,Sun,et al."Hydrogen Sulfide in Diabetic Complications Revisited: The State of the Art, Challenges, and Future Directions".ANTIOXIDANTS & REDOX SIGNALING 38.1-3(2023).
|
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | 操作 | |
ars.2022.0028.pdf(1241KB) | -- | -- | 限制开放 | -- |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论